DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced the US launch of Conform Sheet, a hydrated, pliable and totally demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation.
The new allograft implant, processed by the Musculoskeletal Transplant Foundation (MTF), has both osteoinductive and osteoconductive properties.
Through a unique demineralization process, bone morphogenic proteins (BMPs) are exposed, providing Conform Sheet its osteoinductive properties, while the cancellous structure of the scaffold provides osteoconductive characteristics.
Conform Sheet is wickable in that it readily absorbs various hydrating fluids including bone marrow aspirate, blood or saline. When combined with bone marrow aspirate, Conform Sheet becomes osteogenic.
Conform Sheet is offered in four sizes, which may be cut to accommodate irregular shaped anatomy. The implant may be used with DePuy Synthes Spine MATRIX MIS Pedicle Screw System and Expedium Spine System, as well as other systems for spinal fusion.
DePuy Synthes Spine worldwide president Max Reinhardt noted by adding Conform Sheet to the company’s Spine portfolio, it continues to provide customers with robust procedural solutions to treat their spine patients.
"We are pleased to collaborate across DePuy Synthes Companies with our Biomaterials colleagues to offer complete solutions that advance patient care. This is an excellent example of how, together, DePuy Synthes Companies can meet the needs of hospitals and health care systems," Reinhardt added.
DePuy Synthes Spine also offers Conform Cube= Demineralized Cancellous Bone, which launched in 2011. Conform Cube is another fully demineralized cancellous bone product in the form of a cube. The implant comes in five sizes and has the same properties as the Conform Sheet, but does not come pre-hydrated.
Conform Sheet and Conform Cube are processed by MTF, resulting in tissue quality and safety through their approach to donor selection and allograft processing.